N/A N=117 Supportive Care

IntelliCare in College Students - Implementation (ICCS-I)

Depression · Anxiety

Bottom Line

View on ClinicalTrials.gov: NCT04108429 ↗

Enrolled (actual)

117

Serious AEs

0.0%

Results posted

Mar 2022

Primary outcome: Primary: Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity Module — 11.2; 9.5; 10.9; 9.4 units on a scale — p=.830

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: IntelliCare for College Students (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Northwestern University
Primary completion: Dec 2020

Outcome Measures

Outcome	Result	p-value
PRIMARY Patient Health Questionnaire - 9 (PHQ-9) - Depression Severity Module	11.2; 9.5; 10.9; 9.4; 9.1	.830
PRIMARY Generalized Anxiety Disorder Scale - 7 (GAD-7)	10.0; 8.6; 9.0; 9.4; 10.3	.759
PRIMARY Counseling Center Utilization Data (e.g. Counts of Individual Counseling Appointments)	25.4; 117.1; 9.7; 99.8; 224.6; 531.5	.275
PRIMARY Average Number of Days of App Usage	6.29	—
SECONDARY Anxiety Literacy Questionnaire	14.4; 15.6; 14.1	.002 sig
SECONDARY Depression Literacy Questionnaire	16.2; 17.0; 16.7	.489
SECONDARY Cognitive and Behavioral Response to Stress Scale (CB-RSS)	9.9; 11.2; 8.02; 9.5; 9.7; 7.3	.001 sig

Summary

This study is a hybrid effectiveness-implementation trial of the smartphone student stress-management app IntelliCare for college students. This intervention will be tested with University of Illinois at Chicago (UIC) and Northern Illinois University (NIU) students. During the study, participants will complete measures of depressive and anxious symptoms, as well as measures of mental health literacy, within the app.

Eligibility Criteria

Inclusion Criteria

Participant is a student at the University of Illinois in Chicago or Northern Illinois University. *Participant owns a smartphone capable of running Android 7 (or higher) or iOS11 (or higher).
Participant is 18 years of age or older

Exclusion Criteria

*None

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04108429). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.